Search

Displaying results 5401 - 5410 of 6949 in total
  1. Drug

    Proglumide

    go.drugbank.com/drugs/DB13431
    Investigational

    Categories: Drugs for Acid Related Disorders, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
  2. Drug

    Cefetamet

    go.drugbank.com/drugs/DB13504
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  3. Drug

    Propicillin

    go.drugbank.com/drugs/DB13660
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  4. Drug

    MDX-1379

    go.drugbank.com/drugs/DB05329
    Investigational

    MDX-1379 vaccine consists of two gp100 melanoma peptides. This drug is underinvestigation to treat malignant melanoma.

  5. Drug

    Ethylmorphine

    go.drugbank.com/drugs/DB01466
    IllicitInvestigational

    It is not marketed in the US but is approved for use in various countries around the world. In the US it is a schedule II drug (single-entity) and schedule III drug (in combination products).

  6. Drug

    Sacubitril

    go.drugbank.com/drugs/DB09292
    ApprovedInvestigational

    It was approved by the FDA after being given the status of priority review for on July 7, 2015.

  7. Drug

    BMN-351

    go.drugbank.com/drugs/DB18186
    Investigational

    It is under investigation for the treatment of Duchenne Muscular Dystrophy (DMD).

  8. Drug

    Insulin efsitora alfa

    go.drugbank.com/drugs/DB19013
    Investigational

    alfa is under investigation in clinical trial NCT05662332 (A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for

  9. Drug

    ZB131

    go.drugbank.com/drugs/DB17164
    Investigational

    ZB131 is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin (CSP), a cell surface protein identified in a wide range of cancers that correlates with poor prognosis and

  10. Drug

    Latrunculin A

    go.drugbank.com/drugs/DB02621
    Investigational

    It is under investigation for the treatment of cancer. It disrupts actin polymerization, prevents mitotic spindle formation and thus cell replication.